MITO - Stealth BioTherapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Stealth BioTherapeutics Corp's activity chart (see below) currently has 14 price targets and 15 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.18% with an average time for these price targets to be met of 35.45 days.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 23-May-2022. First documented stock forecast 12-Mar-2019.

Best performing analysts who are covering MITO - Stealth BioTherapeutics Corp:

Matthew Luchini Christopher Marai Yi Chen Maury Raycroft Joshua Schimmer Charles Duncan

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-Mar-2019

$1.75

$1.43 (446.88%)

$16

Hold Since 02-Apr-2020

$2

$1.68 (525.00%)

Show more analysts

Please expand the browser size to see the chart

What is MITO (Stealth BioTherapeutics Corp) average time for price targets to be met?

On average it took 35.45 days on average for the stock forecasts to be realized with a an average price target met ratio 18.18

Which analyst has the current highest performing score on MITO (Stealth BioTherapeutics Corp) with a proven track record?

MATTHEW LUCHINI

Which analyst has the most public recommendations on MITO (Stealth BioTherapeutics Corp)?

Matthew Luchini has 3 price targets and 3 ratings on MITO

Which analyst is the currently most bullish on MITO (Stealth BioTherapeutics Corp)?

Charles Duncan with highest potential upside - $9.68

Which analyst is the currently most reserved on MITO (Stealth BioTherapeutics Corp)?

Christopher Marai with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?